Open AccessPrognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer
Author(s) -
Sabine Tejpar,
Sebastian Stintzing,
Fortunato Ciardiello,
Josep Tabernero,
Eric Van Cutsem,
Frank Beier,
Regina Esser,
HeinzJosef Lenz,
Volker Heinemann
Publication year - 2016
Publication title -
jama oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 8.846
H-Index - 99
eISSN - 2374-2445
pISSN - 2374-2437
DOI - 10.1001/jamaoncol.2016.3797
Subject(s) - folfiri , medicine , cetuximab , irinotecan , colorectal cancer , bevacizumab , splenic flexure , oncology , primary tumor , gastroenterology , cancer , metastasis , colonoscopy , chemotherapy
Metastatic colorectal cancer (mCRC) is heterogeneous, and primary tumors arising from different regions of the colon are clinically and molecularly distinct.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom